1-5 of 5
O George Negrea, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monotherapy with Subcutaneous (SC) Injections of Low Doses of Humanized Anti-CD20 Veltuzumab Is Active in Chronic Lymphocytic Leukemia (CLL)

Matt Kalaycio, MD, O George Negrea, MD, Rebecca Elstrom, MD, Charles Farber, MD, PhD, Heather Horne, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2012) 120 (21): 192.
https://doi.org/10.1182/blood.V120.21.192.192
Published: 2012
Journal Articles

Phase I/II Study of Monotherapy with Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia

Howard A. Liebman, MA, MD, Mansoor N Saleh, MD, James B. Bussel, MD, O George Negrea, MD, Heather Horne, William Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2012) 120 (21): 622.
https://doi.org/10.1182/blood.V120.21.622.622
Published: 2012
Journal Articles

Phase I/II Study of Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia,

Howard A Liebman, MD, Mansoor N Saleh, MD, James B Bussel, MD, Zale P Bernstein, MD, O George Negrea, MD, Anthony C Onyegbula, DO, Charles M Farber, MD, PhD, Heather Horne, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2011) 118 (21): 3302.
https://doi.org/10.1182/blood.V118.21.3302.3302
Published: 2011
Journal Articles

Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab for Treatment of Relapsed Immune Thrombocytopenia (ITP).

Mansoor N Saleh, MD, Howard Liebman, MD, Zale P. Bernstein, MD, O. George Negrea, MD, James B. Bussel, MD, Anthony C. Onyegbula, DO, Charles M Farber, MD, PhD, Rashid Abassi, MD, Thomas M. Cosgriff, MD, Kenneth Pennington, MD, Heather Horne, Nick Teoh, PhD, Asraf Gomaa, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2009) 114 (22): 1322.
https://doi.org/10.1182/blood.V114.22.1322.1322
Published: 2009
Journal Articles

Subcutaneous Injections of Low Doses of Humanized Anti-CD20 Veltuzumab for Treatment of Indolent B-Cell Malignancies.

O. George Negrea, MD, Steven L Allen, Kanti R. Rai, MD, Rebecca Elstrom, MD, Rashid Abassi, MD, Charles M Farber, MD, PhD, Nick Teoh, PhD, Heather Horne, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2009) 114 (22): 3757.
https://doi.org/10.1182/blood.V114.22.3757.3757
Published: 2009